(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 4.82% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.92%.
Bruker's revenue in 2026 is $3,438,900,000.On average, 18 Wall Street analysts forecast BRKR's revenue for 2026 to be $552,154,117,296, with the lowest BRKR revenue forecast at $512,345,537,568, and the highest BRKR revenue forecast at $573,729,759,744. On average, 18 Wall Street analysts forecast BRKR's revenue for 2027 to be $574,185,583,176, with the lowest BRKR revenue forecast at $533,009,533,152, and the highest BRKR revenue forecast at $603,510,223,968.
In 2028, BRKR is forecast to generate $603,206,341,680 in revenue, with the lowest revenue forecast at $564,765,232,248 and the highest revenue forecast at $642,711,039,120.